Estradiol sustained release from high affinity cyclodextrin hydrogels.

Area of Science:

• Materials Science
• Polymer Chemistry
• Pharmaceutical Sciences

Background:

• Developing effective drug delivery systems for hydrophobic drugs remains a challenge.
• Hydrogels offer potential for controlled drug release applications.
• Cyclodextrins are known for their ability to form inclusion complexes with drugs.

Purpose of the Study:

• To prepare and characterize estradiol-loaded hydrogels using various cyclodextrins.
• To investigate the influence of cyclodextrin type and concentration on hydrogel properties and drug loading/release.
• To evaluate the sustained release of estradiol from the developed hydrogels.

Main Methods:

• Preparation of hydrogels by cross-linking cyclodextrins (betaCD, MbetaCD, HPbetaCD, SBbetaCD) with ethyleneglycol diglycidyl ether.
• Solubility studies of estradiol in the presence of different cyclodextrins and hydroxypropyl methylcellulose (HPMC).
• Characterization of hydrogel swelling, drug loading capacity, and in vitro drug release kinetics.

Main Results:

• Hydrogels prepared with methyl-beta-cyclodextrin (MbetaCD) and hydroxypropyl-beta-cyclodextrin (HPbetaCD) showed good performance.
• Estradiol loading capacity was significantly enhanced (up to 24 mg/g), exceeding drug solubility in the aqueous phase by 500 times.
• Sustained release of estradiol was achieved for up to one week, correlated with the affinity of estradiol for cyclodextrin units.

Conclusions:

• Cyclodextrin-based hydrogels are effective for high-capacity loading of hydrophobic drugs like estradiol.
• The complexation affinity between cyclodextrin and the drug plays a crucial role in controlling release rates.
• These hydrogels represent a promising platform for developing advanced drug delivery systems.